GT Biopharma
GTBP
GTBP
55 hedge funds and large institutions have $16.7M invested in GT Biopharma in 2021 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 23 increasing their positions, 6 reducing their positions, and 11 closing their positions.
Holders
55
Holders Change
+1
Holders Change %
+1.85%
% of All Funds
0.85%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
23
Reduced
6
Closed
11
Calls
$334K
Puts
$239K
Net Calls
+$95K
Net Calls Change
+$467K
Top Buyers
1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$3.68M |
2 |
2
Renaissance Technologies
New York
|
$935K |
3 |
3
Morgan Stanley
New York
|
$1.35M |
4 |
4
Two Sigma Advisers
New York
|
$366K |
5 |
5
State Street
Boston,
Massachusetts
|
$1.6M |